Demonstration of glycosaminoglycans in Caenorhabditis elegans  by Yamada, Shuhei et al.
Demonstration of glycosaminoglycans in Caenorhabditis elegans
Shuhei Yamadaa, Irma Van Dieb, Dirk H. Van den Eijndenb, Akiko Yokotaa,
Hiroshi Kitagawaa, Kazuyuki Sugaharaa;*
aDepartment of Biochemistry, Kobe Pharmaceutical University, 4-19-1 Motoyamakita-machi, Higashinada-ku, Kobe 658-8558, Japan
bDepartment of Medical Chemistry, Vrije Universiteit, 1081 BT Amsterdam, The Netherlands
Received 29 July 1999; received in revised form 9 September 1999
Abstract A considerable amount (approximately 1.6 Wg from
1 mg of dried nematode) of non-sulfated chondroitin, two orders
of magnitude less yet an appreciable amount of heparan sulfate,
and no hyaluronate were found in Caenorhabditis elegans
nematodes. The chondroitin chains were heterogeneous in size,
being shorter than that of whale cartilage chondroitin sulfate.
The disaccharide composition analysis of heparan sulfate
revealed diverse sulfation including glucosamine 2-N-sulfation,
glucosamine 6-O-sulfation and uronate 2-O-sulfation. These
results imply that chondroitin and heparan sulfate are involved in
fundamental biological processes.
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1. Introduction
Glycosaminoglycans (GAGs) have been implicated in the
regulation and maintenance of cell adhesion, motility, prolif-
eration, di¡erentiation, tissue morphogenesis and embryogen-
esis [1^5]. The biological activities of GAGs depend on their
ability to interact with a variety of proteins including growth
factors, cytokines, enzymes, serine protease inhibitors and ex-
tracellular matrix proteins, and many such interactions are
thought to be highly speci¢c re£ecting respective saccharide
sequences embedded in GAG chains, which regulate the phys-
iological functions of these proteins [6]. GAGs have a poly-
saccharide backbone which is a linear polymer composed of
alternating amino sugar and hexuronic acid residues. This
simple repeat structure of GAGs acquires a considerable de-
gree of variability by extensive modi¢cations involving sulfa-
tions and uronate epimerization [7]. Such structural variability
of GAGs is the basis for the wide variety of domain structures
with biological activities [2] and is generated by the elaborate,
concerted actions of biosynthetic enzymes. Over the past sev-
eral years, cDNAs of a number of the biosynthetic enzymes
for GAGs have been cloned. Thus, the opportunity has ar-
rived for modern GAG glycobiology to develop.
Investigation of the occurrence of GAGs in tissues of verte-
brates and invertebrates has shown a wide distribution in the
animal kingdom [8], suggesting that GAGs are phylogeneti-
cally conserved through evolution, and play fundamental bio-
logical roles in animal development. The nematode Caeno-
rhabditis elegans is an ideal experimental organism for
studying a wide range of fundamental biological disciplines
in development using modern techniques of molecular and
cell biology since it is a small, rapidly growing, multicellular
organism with characteristic nervous, muscle, digestive and
reproductive systems. The progress made in the C. elegans
genome project has revealed the existence of multiple genes
that are related to GAG-synthesizing enzymes and appear to
be ancestors of vertebrate counterparts. However, there is no
direct evidence for the existence of GAGs in C. elegans. In
this study we isolated and characterized a non-sulfated chon-
droitin and heparan sulfate (HS) in adult worms.
2. Materials and methods
2.1. Materials
Chondroitinase ABC (EC 4.2.2.4), chondroitinase AC-II (EC
4.2.2.5), chondroitinase B (EC 4.2.2.), heparinase (EC 4.2.2.7), hepar-
itinase I (EC 4.2.2.8), heparitinase II (no EC number), Streptomyces
hyaluronidase (EC 4.2.2.1), whale cartilage chondroitin sulfate (CS)
A, human umbilical cord hyaluronic acid and standard unsaturated
disaccharides derived from CS and HS were obtained from Seikagaku,
Tokyo, Japan. Glycuronate 2-sulfatase was a gift from Dr. Keiichi
Yoshida (Seikagaku). Sephadex gels and prepacked Superdex 75 and
Superdex 200 columns (10U300 mm) were purchased from Amer-
sham Pharmacia Biotech, Tokyo, Japan.
2.2. Preparation of a GAG fraction from C. elegans
Wild-type C. elegans (strain N2, Bristol) were cultured on NGM
plates seeded with Escherichia coli strain OP50, as described [9].
Freshly cultured nematodes were homogenized with a polytron and
freeze-dried. The dried sample (60 mg) was extracted with acetone and
then treated with 14 ml of 1.0 M NaBH4/0.05 M NaOH at room
temperature for 2 h. Acetic acid was added to stop the reaction.
The sample was adjusted to 5% trichloroacetic acid and centrifuged.
The soluble fraction was extracted with ether and the aqueous phase
was adjusted to 80% ethanol. The resultant precipitate was dissolved
in water and subjected to gel ¢ltration chromatography on a column
of Sephadex G-50 (¢ne) using 0.25 M NH4HCO3/7% 1-propanol as
an eluent.
2.3. Enzymatic digestion
Digestion with chondroitinases ABC, AC-II or B, or a mixture of
heparinase and heparitinases I and II was conducted as described
previously [10,11]. Successive enzymatic digestion with heparitinases
and then glycuronate 2-sulfatase was carried out as follows. Samples
were ¢rst digested with heparitinases for 1 h at 37‡C in a total volume
of 30 Wl and reactions were terminated by boiling for 1 min. The
reaction mixture was mixed with 10 Wl of water and 20 Wl of 20
mM acetate-Na bu¡er, pH 6.5, containing 0.15% bovine serum albu-
min and 3 mIU of glycuronate 2-sulfatase, then incubated at 37‡C for
1 h. Streptomyces hyaluronidase digestion was also carried out as
follows. Samples were incubated with 2 mIU of the enzyme for 30
min at 60‡C in a total volume of 20 Wl of 100 mM acetate bu¡er, pH
5.0. Reactions were terminated by boiling for 1 min and the reaction
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mixture was analyzed by high-performance liquid chromatography
(HPLC) on an amine-bound silica column as reported previously
[12]. The heparitinase digests were derivatized with 2-aminobenzamide
(2-AB) then analyzed by HPLC as reported previously [13].
2.4. 500 MHz 1H NMR spectroscopy
Samples for NMR analysis were repeatedly exchanged in 2H2O
with intermediate lyophilization. The 500-MHz 1H NMR spectra
were measured on a Varian-500 at a probe temperature of 26‡C using
a Nano-NMR probe containing 40 Wl of the sample solution. The
Nano-NMR probe spins samples rapidly at the magic angle to remove
the magnetic-susceptibility contributions to the 1H NMR line widths
[14]. The spin rate was typically about 2 kHz. Chemical shifts are
given relative to sodium 4,4-dimethyl-4-silapentane-1-sulfonate, but
were actually measured indirectly relative to acetone (N 2.225) in
2H2O [15].
2.5. Gel ¢ltration chromatography of C. elegans chondroitin
The C. elegans GAG fraction was analyzed by gel ¢ltration chro-
matography on a column (10U300 mm) of Superdex 75 or Superdex
200 eluted with 50 mM pyridine-acetate bu¡er, pH 5.0, at a £ow rate
of 1 ml/min in a Pharmacia FPLC system (Amersham Pharmacia
Biotech, Tokyo, Japan). Fractions were collected at 1.0-min intervals,
lyophilized and digested with chondroitinase ABC. The digests were
derivatized with 2-AB then analyzed by HPLC on an amine-bound
silica column [13].
3. Results
To investigate the existence of GAGs in C. elegans, a GAG
fraction was prepared from the acetone powder of the crude
homogenate of the worms. The acetone powder was treated
with alkaline NaBH4 to release GAGs from putative core
proteins and a GAG fraction was recovered by ethanol pre-
cipitation followed by gel ¢ltration on a Sephadex G-50 col-
umn. An analysis was carried out on this fraction by HPLC to
identify the disaccharides produced by digestion with speci¢c
GAG lyases.
Upon digestion with chondroitinase ABC, a single major
peak was detected at the elution position of the authentic non-
sulfated chondroitin disaccharide, vHexAK1-3GalNAc, and
no other peaks were detected at the sulfated disaccharide po-
sitions (Fig. 1). Chondroitinase ABC acts not only on chon-
droitin yielding vHexAK1-3GalNAc but also on hyaluronic
acid producing vHexAK1-3GlcNAc [16]. Since both disac-
charides are eluted at the same position on HPLC under the
conditions used [12], the peak was identi¢ed as vHexAK1-
3GalNAc based on the resistant nature of the GAG fraction
to the action of Streptomyces hyaluronidase (data not shown),
which is speci¢c for hyaluronic acid but not for chondroitin
[17]. Approximately 250 nmol of the unsaturated disaccharide
was recovered by chondroitinase ABC digestion from 60 mg
of dried worms.
To further elucidate the structure of vHexAK1-3GalNAc,
the chondroitinase ABC digestion product was analyzed by
500 MHz 1H NMR spectroscopy (data not shown). Proton
NMR spectroscopy is a powerful tool in obtaining structural
information about complex carbohydrates [15]. Advanced 1H-
Fig. 1. HPLC analysis of the chondroitinase ABC digest of the C.
elegans GAG fraction. The chondroitinase ABC digest of the C. ele-
gans GAG fraction was analyzed by HPLC on an amine-bound sili-
ca column. The peak eluted at around 5 min and marked by an as-
terisk in the lower panel is an acetate ion derived from the
incubation bu¡er. The elution positions of authentic unsaturated
disaccharides are indicated by arrows. 1, vHexAK1-3GalNAc;
2, vHexAK1-3GalNAc(6-O-sulfate); 3, vHexAK1-3GalNAc(4-O-sul-
fate); 4, vHexA(2-O-sulfate)K1-3GalNAc(6-O-sulfate); 5, vHexAK1-
3GalNAc(4,6-O-disulfate); 6, vHexA(2-O-sulfate)K1-3GalNAc(4,6-
O-disulfate).
Table 1
1H-Chemical shifts of the oligosaccharide prepared by chondroitinase ABC digestion
Reporter groups Reference compounda Chondroitinase ABC digest
K L K L
GalNAc H-1 5.215 (4.0b) 4.710 (8.5) 5.216 (4.0) 4.737 (8.0)
H-2 4.285 3.989 4.269 3.944
H-3 4.103 3.927 4.09 3.91
H-4 4.176 4.106 4.14 4.08
H-5 4.142 NDc ND 3.72
H-6 ND ND 3.69 - 3.72 3.62 - 3.68
H-6’ ND ND 3.69 - 3.72 3.62 - 3.68
NAc 2.055 2.055 2.056 2.059
vHexA H-1 5.245 (4.5) 5.197 (4.5) 5.261 (4.0) 5.228 (4.5)
H-2 3.810 3.807 3.821
H-3 4.099 4.099 4.09
H-4 5.904 5.904 5.924
Chemical shifts are given in ppm down¢eld from internal sodium 4,4-dimethyl-4-silapentane-1-sulfonate, but were actually measured indirectly
in reference to acetone (N 2.225 ppm) in 2H2O at 26‡C. The estimated error for the values to two decimal places was only þ 0.01 ppm because
of partial overlap of signals. That for the values to three decimal places was þ 0.002 ppm.
aReference compound is the non-sulfated disaccharide derived from chondroitin, vHexAK1-3GalNAc [18].
bCoupling constants J1;2 (in Hz) are given in parentheses.
cND, not determined.
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NMR methods are suitable for determining the proton chem-
ical shifts, which indicate the presence, type and location of
substituents, such as acetyl, methyl, phosphate and sulfate
groups[15]. The proton chemical shifts were assigned using
two-dimensional homonuclear Hartmann-Hahn and correla-
tion spectroscopy (data not shown) and the NMR data are
summarized in Table 1. The data were virtually identical with
those reported previously for the authentic vHexAK1-3Gal-
NAc [18], indicating that the disaccharide is derived from
chondroitin, but not from hyaluronic acid and that no struc-
tural modi¢cations by any uncharged groups or sulfate are
present.
The C. elegans GAG fraction was resistant to the action of
chondroitinase B but sensitive to that of chondroitinase AC-
II, indicating that the non-sulfated unsaturated disaccharide is
derived from chondroitin, which is composed of -4GlcAL1-
3GalNAcL1- units, rather than dermatan composed of -4Id-
ceAK1-3GalNAcL1- units [16].
The molecular size of the C. elegans chondroitin was ana-
lyzed by gel ¢ltration chromatography. It was eluted in the
£ow-through fraction of a Superdex 75 column but included
in a Superdex 200 column. To monitor small amounts of
chondroitin, aliquots of individual fractions collected at 1.0-
min intervals were lyophilized and digested with chondroiti-
nase ABC, then the products were derivatized with a £uoro-
phore 2-AB [13] and analyzed by HPLC. The amount of the
2-AB derivatized disaccharide product vHexAK1-3GalNAc
was calculated based on its £uorescence intensity. Since mo-
lecular weight standards of chondroitin oligosaccharides with
appropriate sizes were not available, the molecular mass of
the C. elegans chondroitin was compared with commercial
whale cartilage CS-A (25^50 kDa). As shown in Fig. 2, a
broad peak of the C. elegans chondroitin was observed, in-
dicating the heterogeneous sizes, and the average chain length
was shorter than that of commercial CS-A.
The C. elegans GAG fraction was also subjected to HS
disaccharide composition analysis after digestion with a mix-
ture of heparinase, heparitinases I and II. Since the amount of
the disaccharide products obtained was far less than that of
chondroitin, the resulting disaccharides were labeled with a
£uorophore 2-AB and analyzed by HPLC on an amine-bound
silica column. The chromatogram obtained after removal of
the reagent (2-AB) by paper chromatography is shown in Fig.
3. Based on the £uorescence intensity, the yield of each di-
saccharide was calculated and the data are summarized in
Table 2. Most of the non-sulfated disaccharide product vHex-
AK1-3GlcNAc is lost during the paper chromatographic
puri¢cation of 2-AB derivatives as reported previously [13]
and peaks of some contaminants derived from the paper strip
used for removing the reagent were detected at around the
elution position of the non-sulfated disaccharide as can be
seen in Fig. 3B. Hence, the non-sulfated disaccharide was
quanti¢ed by injecting another aliquot before removing the
reagent (data not shown), which gave a sharp distinguishable
peak of the non-sulfated disaccharide as reported [13]. The
total amount of HS disaccharides produced by digestion
with heparitinases was only 1.7 nmol per 60 mg of dried
worms, two orders of magnitude less than that of chondroitin.
The identity of the disaccharide peaks eluted at the positions
of vHexA(2-O-sulfate)K1-4GlcN(2-N-sulfate) and vHexA(2-
O-sulfate)K1-4GlcN(2-N-,6-O-disulfate) were established
based on the sensitivity to glycuronate 2-sulfatase, which hy-
drolyzes the sulfate ester bond of the 4,5-unsaturated uronic
acid 2-O-sulfate structure at the non-reducing end of disac-
charides [19]. Upon the digestion, these peaks were shifted
indeed to the positions of vHexAK1-4GlcN(2-N-sulfate) and
vHexAK1-4GlcN(2-N-,6-O-disulfate), respectively (data not
shown). Due to a limited availability of these disaccharides,
it was not feasible to measure 1H NMR spectra of the di-
saccharides.
4. Discussion
The complete genome sequence of C. elegans (1U108 bp)
has been determined, and a number of developmentally im-
portant genes have been revealed. However, the glycobiology
and conventional biochemistry of C. elegans have advanced
less than the genetics, anatomy, neurobiology and develop-
Fig. 2. Molecular size analysis of the C. elegans chondroitin on gel
¢ltration chromatography. The C. elegans GAG fraction (corre-
sponding to 1.2 nmol of chondroitin) was subjected to gel ¢ltration
chromatography on a Superdex 200 column. The chondroitinase
ABC digests of individual fractions were derivatized with 2-AB then
analyzed by HPLC. The amount of the 2-AB derivative of vHex-
AK1-3GalNAc was calculated based on £uorescence intensity (solid
line). V0 and Vt were determined using human umbilical cord hya-
luronic acid and NaCl, respectively. The broken line indicates the
elution pro¢le of the whale cartilage CS-A, the molecular mass of
which was reported to be 25^50 kDa by the manufacturer. It was
monitored by measurement of the absorbance at 210 nm after each
fraction was dried and resolved in distilled water.
Table 2
Disaccharide composition analysis of C. elegans HS
Disaccharides Proportion (mol%)
vHexAK1-4GlcNAc 47
vHexAK1-4GlcNAc(6Sa) 6
vHexAK1-4GlcN(NS) 14
vHexAK1-4GlcN(NS,6S) NDb
vHexA(2S)K1-4GlcN(NS) 18
vHexA(2S)K1-4GlcN(NS,6S) 15
a6S, NS or 2S represents 6-O-sulfate, 2-N-sulfate, or 6-O-sulfate, re-
spectively.
bND, not detected.
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mental biology. Although many genes that encode the puta-
tive GAG-synthesizing enzymes have been identi¢ed, no direct
evidence has been presented for the existence of GAGs in C.
elegans so far. In the present study, we isolated and charac-
terized GAGs from adult worms of C. elegans and demon-
strated the existence of chondroitin and HS. A considerable
amount (approximately 1.6 Wg from 1 mg of dried nematode)
of non-sulfated chondroitin, a far less yet appreciable amount
of HS and no hyaluronate were detected under the conditions
used. E. coli OP50, which was supplied as food for C. elegans,
contained no GAGs (data not shown), con¢rming that the
nematode chondroitin and HS were not derived from the bac-
teria but synthesized by the worms themselves.
The putative genes encoding a few HS glycosyltransferases
as well as several HS sulfotransferases have been identi¢ed in
the C. elegans genome. The former include HS polymerase
[20] and glucuronyltransferase I for the synthesis of the
GAG-protein linkage region tetrasaccharide [21]. The lat-
ter include glucosaminyl N-deacetylase/N-sulfotransferase
[22,23], uronyl 2-O-sulfotransferase [24], glucosaminyl 3-O-
sulfotransferase [25] and glucosaminyl 6-O-sulfotransferase
[26]. Although none of the above enzyme activities in the
worm homogenate have been demonstrated and no evidence
of the in vitro expression of these enzyme activities has been
presented so far, the existence of these putative genes appears
to be consistent with our observations that HS existed in the
worm and was extensively sulfated. The wide distribution of
HS demonstrated to date in the animal kingdom and the
existence of extensively sulfated HS in C. elegans demon-
strated in this study strongly support the notion that the
highly sulfated structural characteristics of HS have been
maintained throughout evolution and HS chains speci¢cally
modi¢ed by epimerization and sulfation reactions are required
for fundamental biological events. In fact, the important role
of HS proteoglycans in ¢broblast growth factor signaling has
been particularly well documented [27]. The biological func-
tions of ¢broblast growth factors include the regulation of cell
proliferation, di¡erentiation and tissue patterning, where HS
has been implicated in stabilizing or inducing the formation of
¢broblast growth factor dimers or a ternary complex com-
posed of ligand plus high and low a⁄nity receptors [6]. In
addition, recent studies have demonstrated a critical role for
HS in Wingless signaling which is required for dorsal-ventral
patterning during Drosophila development [28]. In addition,
Drosophila homologues of a putative HS polymerase EXT1
and HS 2-O-sulfotransferase (encoded by ttv and pipe, respec-
tively) were recently implicated in the Hedgehog di¡usion and
the formation of embryonic dorsal-ventral polarity, respec-
tively [29,30].
In contrast to the advanced development of the molecular
cloning of the biosynthetic enzymes involved in HS, the num-
ber of cloned enzymes involved in CS biosynthesis is much
limited. No cDNA cloning of glycosyltransferases for the syn-
thesis of the repeating disaccharide unit of the chondroitin
backbone has been reported. Chondro-6-sulfotransferase
[31,32] is the only cloned biosynthetic enzyme for CS. No
homologue of this sulfotransferase gene is found in the C.
elegans genome, being consistent with our observation of
non-sulfated chondroitin in the worm. Although a C. elegans
homologue of the recently reported chondroitin/dermatan ur-
onyl 2-O-sulfotransferase [33] is present in the C. elegans ge-
nome, its homology is higher to HS uronyl 2-O-sulfotransfer-
ase than chondroitin/dermatan uronyl 2-O-sulfotransferase
[33]. Thus, it may be that sulfotransferases for CS evolved
later than those for HS. Several lines of evidence have sug-
gested the involvement of CS proteoglycans in the develop-
ment and maintenance of the neural network in mammalian
brain and peripheral nerves [34^36] and sulfation of chondroi-
tin may be required for the functions of this class of poly-
saccharides in evolutionary higher animals. It remains to be
determined whether HS and chondroitin chains are covalently
bound to proteins as in vertebrates. In this regard, it should
be noted that the sqv-8 gene homologous to the glucuronyl-
transferase I gene [21] for the synthesis of the GAG-protein
linkage region common to HS and CS is present in the C.
elegans genome, although it is also homologous to the glucur-
onyltransferase genes involved in the synthesis of the HNK-1
carbohydrate epitope. Interestingly, mutations of sqv-8 per-
turb vulval invagination in C. elegans [37], which may suggest
the involvement of GAGs in the tissue morphogenesis.
Although a homologous gene (accession number: Z72516)
of human and murine hyaluronan synthase is found in the C.
elegans genome [38] despite that hyaluronan was not detected
in the present study, it may be associated with chitin synthesis
as assumed from its homology to chitin synthase [39]. Alter-
natively, hyaluronan may be present below the detection limit
of the present method. Since the detection limit of the micro-
analysis using 2-AB was a subpicomolar level (V0.5 pmol),
the amount of hyaluronan, if any, is less than 5 ng per 1 mg of
dried nematode. Future systematic functional analyses of mul-
tiple genes associated with GAG biosynthesis along with the
Drosophila and human genome projects should provide us
with enough new information to elucidate the biological func-
tions and evolutionary signi¢cance of the non-sulfated and
sulfated GAGs.
Fig. 3. HPLC analysis of the digest of the C. elegans GAG fraction
with a mixture of heparinase and heparitinases I and II. Upper pan-
el (A), the 2-AB derivatives of standard unsaturated HS disacchar-
ides. 1, vHexAK1-4GlcNAc; 2, vHexAK1-4GlcNAc(6-O-sulfate); 3,
vHexAK1-4GlcN(2-N-sulfate); 4, vHexAK1-4GlcN(2-N-,6-O-disul-
fate); 5, vHexA(2-O-sulfate)K1-4GlcNAc(2-N-sulfate); 6, vHexA(2-
O-sulfate)K1-4GlcNAc(2-N-,6-O-disulfate). Lower panel (B), the 2-
AB derivative of the digest of the C. elegans GAG fraction with a
mixture of heparinase and heparitinases I and II. The peaks eluted
at around 4 min is due to the reagent (2-AB), which was carried
over from the puri¢cation step of 2-AB derivatives. The peaks
marked by asterisks in the lower panel are due to unknown sub-
stances derived from the GAG preparation, the enzyme preparation,
or the column resin upon high sensitivity analysis.
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